These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 34078743)
61. Immune history profoundly affects broadly protective B cell responses to influenza. Andrews SF; Huang Y; Kaur K; Popova LI; Ho IY; Pauli NT; Henry Dunand CJ; Taylor WM; Lim S; Huang M; Qu X; Lee JH; Salgado-Ferrer M; Krammer F; Palese P; Wrammert J; Ahmed R; Wilson PC Sci Transl Med; 2015 Dec; 7(316):316ra192. PubMed ID: 26631631 [TBL] [Abstract][Full Text] [Related]
62. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses. Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203 [TBL] [Abstract][Full Text] [Related]
63. The 2009 Pandemic H1N1 Hemagglutinin Stalk Remained Antigenically Stable after Circulating in Humans for a Decade. Christensen SR; Martin ET; Petrie JG; Monto AS; Hensley SE J Virol; 2022 Jun; 96(11):e0220021. PubMed ID: 35588275 [TBL] [Abstract][Full Text] [Related]
64. Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice. O'Donnell CD; Vogel L; Wright A; Das SR; Wrammert J; Li GM; McCausland M; Zheng NY; Yewdell JW; Ahmed R; Wilson PC; Subbarao K mBio; 2012; 3(3):. PubMed ID: 22647789 [TBL] [Abstract][Full Text] [Related]
65. Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets. Krammer F; Hai R; Yondola M; Tan GS; Leyva-Grado VH; Ryder AB; Miller MS; Rose JK; Palese P; García-Sastre A; Albrecht RA J Virol; 2014 Mar; 88(6):3432-42. PubMed ID: 24403585 [TBL] [Abstract][Full Text] [Related]
66. H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice. Margine I; Hai R; Albrecht RA; Obermoser G; Harrod AC; Banchereau J; Palucka K; García-Sastre A; Palese P; Treanor JJ; Krammer F J Virol; 2013 Apr; 87(8):4728-37. PubMed ID: 23408625 [TBL] [Abstract][Full Text] [Related]
68. Characterization of Novel Cross-Reactive Influenza B Virus Hemagglutinin Head Specific Antibodies That Lack Hemagglutination Inhibition Activity. Kirkpatrick E; Henry C; McMahon M; Jiang K; Strohmeier S; van Bakel H; Wilson PC; Krammer F J Virol; 2020 Nov; 94(23):. PubMed ID: 32907980 [TBL] [Abstract][Full Text] [Related]
69. Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans. Dugan HL; Guthmiller JJ; Arevalo P; Huang M; Chen YQ; Neu KE; Henry C; Zheng NY; Lan LY; Tepora ME; Stovicek O; Bitar D; Palm AE; Stamper CT; Changrob S; Utset HA; Coughlan L; Krammer F; Cobey S; Wilson PC Sci Transl Med; 2020 Dec; 12(573):. PubMed ID: 33298562 [TBL] [Abstract][Full Text] [Related]
70. Identification of the dominant non-neutralizing epitope in the haemagglutinin of H7N9 avian influenza virus. Hu Z; Zhao J; Shi L; Hu J; Hu S; Liu X Virus Res; 2021 Jun; 298():198409. PubMed ID: 33819520 [TBL] [Abstract][Full Text] [Related]
72. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Li GM; Chiu C; Wrammert J; McCausland M; Andrews SF; Zheng NY; Lee JH; Huang M; Qu X; Edupuganti S; Mulligan M; Das SR; Yewdell JW; Mehta AK; Wilson PC; Ahmed R Proc Natl Acad Sci U S A; 2012 Jun; 109(23):9047-52. PubMed ID: 22615367 [TBL] [Abstract][Full Text] [Related]
74. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes. Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119 [TBL] [Abstract][Full Text] [Related]
75. Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study. Henry C; Palm AE; Utset HA; Huang M; Ho IY; Zheng NY; Fitzgerald T; Neu KE; Chen YQ; Krammer F; Treanor JJ; Sant AJ; Topham DJ; Wilson PC J Virol; 2019 Nov; 93(21):. PubMed ID: 31434733 [TBL] [Abstract][Full Text] [Related]
76. Evaluation of Next-Generation H3 Influenza Vaccines in Ferrets Pre-Immune to Historical H3N2 Viruses. Allen JD; Ross TM Front Immunol; 2021; 12():707339. PubMed ID: 34475872 [TBL] [Abstract][Full Text] [Related]
77. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses. Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745 [TBL] [Abstract][Full Text] [Related]
78. Comparison of A(H3N2) Neutralizing Antibody Responses Elicited by 2018-2019 Season Quadrivalent Influenza Vaccines Derived from Eggs, Cells, and Recombinant Hemagglutinin. Wang W; Alvarado-Facundo E; Vassell R; Collins L; Colombo RE; Ganesan A; Geaney C; Hrncir D; Lalani T; Markelz AE; Maves RC; McClenathan B; Mende K; Richard SA; Schofield C; Seshadri S; Spooner C; Utz GC; Warkentien TE; Levine M; Coles CL; Burgess TH; Eichelberger M; Weiss CD Clin Infect Dis; 2021 Dec; 73(11):e4312-e4320. PubMed ID: 32898271 [TBL] [Abstract][Full Text] [Related]
79. Development of an mRNA vaccine against a panel of heterologous H1N1 seasonal influenza viruses using a consensus hemagglutinin sequence. Ma N; Xia ZW; Zhang ZG; Nian XX; Li XD; Gong Z; Zhang GM; Le Y; Zhou R; Zhang JY; Yang XM Emerg Microbes Infect; 2023 Dec; 12(1):2202278. PubMed ID: 37067355 [TBL] [Abstract][Full Text] [Related]